Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.
01 1Egis Pharmaceuticals PLC
02 32care4
03 1Alembic Pharmaceuticals Limited
04 18Novartis Pharmaceuticals Corporation
05 1Novartis South Africa (Pty) Ltd
01 1FCT
02 12Film Coated Tablet
03 1Film-Coated Tablet
04 1TABLET
05 1TABLET; ORAL
06 2TABLET;ORAL
07 1Tablet
08 5Blank
01 1Allowed
02 1Approved
03 3Authorized
04 6Marketed
05 1Originator
06 1PRESCRIPTION
07 2Prescription
08 2RX
09 7Blank
01 2KISQALI
02 1KISQALI FEMARA CO-PACK (COPACKAGED)
03 1KRYXANA 200MG
04 18Kisqali
05 1RIBOCICLIB
06 1Ribociclib
01 5Australia
02 1Canada
03 1Denmark
04 1Estonia
05 1Hungary
06 6Norway
07 1South Africa
08 3Spain
09 1Sweden
10 1Switzerland
11 3USA
Expand your portfolio with Egis- value-added generics, API capabilities, and reliable contract services to drive your growth.
Regulatory Info :
Registration Country : Hungary
Brand Name : Ribociclib
Dosage Form : Tablet
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Hungary
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info :
Registration Country : USA
Brand Name : RIBOCICLIB
Dosage Form : TABLET; ORAL
Dosage Strength : 200MG
Packaging :
Approval Date :
Application Number : 215677
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : KISQALI
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 200MG BASE
Packaging :
Approval Date : 2017-03-13
Application Number : 209092
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
LETROZOLE; RIBOCICLIB SUCCINATE
Brand Name : KISQALI FEMARA CO-PACK (COPACKAGED)
Dosage Form : TABLET;ORAL
Dosage Strength : 2.5MG;EQ 200MG BASE
Packaging :
Approval Date : 2017-05-04
Application Number : 209935
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 24/10/2017
Application Number : 66377
Regulatory Info : Allowed
Registration Country : Switzerland
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Marketed
Registration Country : Norway
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Marketed
Registration Country : Norway
Regulatory Info : Prescription
Registration Country : Estonia
Brand Name : Kisqali
Dosage Form : Film-Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date :
Application Number :
Regulatory Info : Prescription
Registration Country : Estonia
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 15-12-2021
Application Number : 1171221005IP
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 04-09-2017
Application Number : 1171221001
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Authorized
Registration Country : Spain
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200MG
Packaging :
Approval Date : 26-01-2024
Application Number : 1171221001IP1
Regulatory Info : Authorized
Registration Country : Spain
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 22-08-2017
Application Number : 28105843516
Regulatory Info : Prescription
Registration Country : Denmark
Regulatory Info : Approved
Registration Country : Sweden
Brand Name : Kisqali
Dosage Form : Film Coated Tablet
Dosage Strength : 200mg
Packaging :
Approval Date : 22-08-2017
Application Number : 2.02E+13
Regulatory Info : Approved
Registration Country : Sweden
Regulatory Info : PRESCRIPTION
Registration Country : Canada
RIBOCICLIB (RIBOCICLIB SUCCINATE)
Brand Name : KISQALI
Dosage Form : TABLET
Dosage Strength : 200MG
Packaging : 21/42/63
Approval Date :
Application Number : 2473569
Regulatory Info : PRESCRIPTION
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Kisqali
Dosage Form :
Dosage Strength :
Packaging : 21
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : Originator
Registration Country : South Africa
Brand Name : KRYXANA 200MG
Dosage Form : FCT
Dosage Strength : 200mg
Packaging : 21X1mg
Approval Date :
Application Number :
Regulatory Info : Originator
Registration Country : South Africa
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
